Technical noteEffect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays
Introduction
There is increasing demand for multiplexed immunoassay systems that allow multiple cytokine determination by using a small amount of samples (Kurkjian et al., 2006, Martins et al., 2006, Nolan and Mandy, 2006, Skogstrand et al., 2005).
The Luminex-100 bead-based system combines the principle of ELISA and fluorescent bead-based flow cytometry and is theoretically capable of measuring up to 100 analytes simultaneously.
An important factor in multiplex assay optimization is the sample diluent; a protein mixture that minimizes disturbing influences such as heterophilic antibodies and unspecific binding. In addition, the diluent optimizes cytokine detection by sample dilution and, at the same time, mimics the sample matrix in the calibration curve (i.e. human serum) to allow accurate interpolation of unknown sample response in an external calibration curve. Diluents, of course, lack potentially disturbing factors such as endogenous cytokines and heterophilic antibodies (de Jager et al., 2005, Muller et al., 2002).
In a 19-plex setup, this paper describes signal intensity, assay sensitivity and background signal levels in relation to the total volume-fraction of serum and protein concentration. We present several methods to determine the quality of a diluent. As an example we used two widely used diluents from R&D Systems; DY997 and RD6. We demonstrate the importance of using a diluent that adequately imitates the sample matrix.
Section snippets
Luminex multiplex assay
Proteins and antibodies used were purchased from R&D Systems (Wiesbaden, Germany) with the exception of recombinant proteins IL-1beta, IL-2, IL-5, IL-6, IL-8, IL-10, IL-13, IFN-gamma which were from Strathmann (Hamburg, Germany), capture antibody IL-4 was from Bioscience (Cambridge, United Kingdom), IL-6, IL-10, IL-13 were from Pelikine (Amsterdam, The Netherlands) and detection antibodies IL-4 and IL-10 were from Bioscience and Pelikine, respectively. All cytokines and proteins were
Influence of different diluents on sensitivity of calibration curves
We compared calibration curves prepared in 100% v/v DY997 and in 50% v/v DY997 + 50% v/v human serum, representative of sample volume fraction used in Luminex assays (Herder et al., 2006). Calibration curves for IL-8, as an example for the effects observed in all investigated cytokines, were calculated using a 5-parameter logistic (PL) function (Fig. 1A). Interestingly, the IL-8 background mean fluorescence intensity (MFI) signal of 50% v/v DY997 + 50% v/v human serum was actually lower than DY997
Conclusions
As shown in this paper for human serum, a diluent needs to mimic the sample matrix when establishing an external calibration curve to allow accurate interpolation of unknown samples. With respect to our specific assay requirements, diluent RD6 from R&D Systems appears to be a more appropriate candidate for cytokine determination using the Luminex system. Our recommendation would be that one should compare several diluents in order to optimize a multiplex setup. More and more companies are
Acknowledgements
We are grateful to Mrs. G. Gornitzka and Mr. Y. Sagik for expert help with the Luminex analyses. We thank Dr. B. Rose, Institute for Clinical Diabetes Research, German Diabetes Center, Duesseldorf, for fruitful discussions.
References (8)
- et al.
Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies
J. Immunol. Methods
(2005) - et al.
Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci
J. Immunol. Methods
(2006) - et al.
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells
Clin. Diagn. Lab. Immunol.
(2003) - et al.
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002 1
Diabetologia
(2006)